Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32369
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dickmann, Catherine G Fitzgerald | - |
dc.contributor.author | McDonald, Alexander F | - |
dc.contributor.author | Huynh, Nhi | - |
dc.contributor.author | Rigopoulos, Angela | - |
dc.contributor.author | Liu, Zhanqi | - |
dc.contributor.author | Guo, Nancy | - |
dc.contributor.author | Osellame, Laura D | - |
dc.contributor.author | Gorman, Michael A | - |
dc.contributor.author | Parker, Michael W | - |
dc.contributor.author | Gan, Hui K | - |
dc.contributor.author | Scott, Andrew M | - |
dc.contributor.author | Ackermann, Uwe | - |
dc.contributor.author | Burvenich, Ingrid J G | - |
dc.contributor.author | White, Jonathan M | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-03-22T02:18:55Z | - |
dc.date.available | 2023-03-22T02:18:55Z | - |
dc.date.issued | 2023-03-09 | - |
dc.identifier.citation | Chemical communications (Cambridge, England) 2023; 59(21): 3126-3129 | en_US |
dc.identifier.issn | 1364-548X | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32369 | - |
dc.description.abstract | Bromodomain and extraterminal (BET) proteins, a family of epigenetic regulators, have emerged as important oncology drug targets. BET proteins have not been targeted for molecular imaging of cancer. Here, we report the development of a novel molecule radiolabelled with positron emitting fluorine-18, [18F]BiPET-2, and its in vitro and preclinical evaluation in glioblastoma models. | en_US |
dc.language.iso | eng | - |
dc.title | Bromodomain and extraterminal protein-targeted probe enables tumour visualisation in vivo using positron emission tomography. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Chemical communications (Cambridge, England) | en_US |
dc.identifier.affiliation | Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. | en_US |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en_US |
dc.identifier.affiliation | Molecular Imaging and Therapy | en_US |
dc.identifier.affiliation | School of Cancer Medicine, La Trobe University, Australia. | en_US |
dc.identifier.doi | 10.1039/d2cc04813b | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-8829-5354 | en_US |
dc.identifier.orcid | 0000-0001-5261-8118 | en_US |
dc.identifier.orcid | 0000-0001-6174-3797 | en_US |
dc.identifier.orcid | 0000-0003-3438-8245 | en_US |
dc.identifier.orcid | 0000-0002-3101-1138 | en_US |
dc.identifier.orcid | 0000-0001-7319-8546 | en_US |
dc.identifier.orcid | 0000-0002-6656-295X | en_US |
dc.identifier.orcid | 0000-0001-9259-2258 | en_US |
dc.identifier.orcid | 0000-0001-8384-2403 | en_US |
dc.identifier.orcid | 0000-0002-0707-6257 | en_US |
dc.identifier.pubmedid | 36809538 | - |
dc.description.volume | 59 | - |
dc.description.issue | 21 | - |
dc.description.startpage | 3126 | - |
dc.description.endpage | 3129 | - |
dc.subject.meshtermssecondary | Positron-Emission Tomography/methods | - |
dc.subject.meshtermssecondary | Glioblastoma/diagnostic imaging | - |
local.name.researcher | Ackermann, Uwe | |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Medical Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
crisitem.author.dept | Molecular Imaging and Therapy | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.